Siever Larry J, Davis Kenneth L
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA.
Am J Psychiatry. 2004 Mar;161(3):398-413. doi: 10.1176/appi.ajp.161.3.398.
This overview focuses on neurobiological abnormalities found in subjects with schizotypal personality disorder, the prototype of the schizophrenia spectrum disorders, and chronic schizophrenia in the context of common vulnerabilities shared by schizotypal personality disorder and schizophrenia, as well as the factors that protect against the severe cognitive/social deficits and frank psychosis of chronic schizophrenia. A pathophysiological model of the relationship between schizotypal personality disorder and schizophrenia was developed based on this data.
The authors provide a selective review of major findings regarding the pathophysiology of schizotypal personality disorder and integrate these results in conjunction with preclinical studies into a model of the pathophysiology of the spectrum.
People with schizotypal personality disorder share phenomenological, genetic, and cognitive abnormalities with people with chronic schizophrenia. While temporal volume reductions appear to be common to both groups, there may be preservation of frontal lobe volume in schizotypal personality disorder compared to schizophrenia. Findings to date regarding striatal volume, metabolic rate, and dopamine release in subjects with schizotypal personality disorder compared to subjects with chronic schizophrenia are consistent with hypotheses of reduced striatal dopaminergic activity in schizotypal personality disorder compared to schizophrenia.
Genetic or environmental factors that promote greater frontal capacity and reduced striatal dopaminergic reactivity might contribute to sparing people with schizotypal personality disorder from the psychosis and severe social and cognitive deterioration of chronic schizophrenia. Further research is required to test these hypotheses more definitively.
本综述聚焦于分裂型人格障碍(精神分裂症谱系障碍的原型)患者以及慢性精神分裂症患者中发现的神经生物学异常,探讨分裂型人格障碍和精神分裂症共有的常见易感性,以及预防慢性精神分裂症严重认知/社会缺陷和明显精神病性症状的因素。基于这些数据建立了分裂型人格障碍与精神分裂症之间关系的病理生理模型。
作者对关于分裂型人格障碍病理生理学的主要研究结果进行了选择性综述,并将这些结果与临床前研究相结合,纳入到一个谱系病理生理模型中。
分裂型人格障碍患者与慢性精神分裂症患者在现象学、遗传学和认知方面存在异常。虽然两组似乎都存在颞叶体积减小,但与精神分裂症相比,分裂型人格障碍患者的额叶体积可能得以保留。与慢性精神分裂症患者相比,目前关于分裂型人格障碍患者纹状体体积、代谢率和多巴胺释放的研究结果与以下假设一致:与精神分裂症相比,分裂型人格障碍患者的纹状体多巴胺能活性降低。
促进额叶能力增强和纹状体多巴胺能反应性降低的遗传或环境因素,可能有助于使分裂型人格障碍患者免于慢性精神分裂症的精神病性症状以及严重的社会和认知衰退。需要进一步研究以更确切地验证这些假设。